SANOFI3,109.80

Sanofi India Limited

· Pharma & Health
₹ CrorePeersSENORESINNOVACAPPGHLMOREPENLABIOLCPSANOFICONRFDCORCHPHARMAMcap ₹7,153 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SANOFI
FY25
SENORES
FY26
INNOVACAP
FY26
PGHL
FY27
Peer
Median
Valuation — at last close
P/E17.33×55.63×47.30×93.84×55.63× -69%
P/B8.31×7.01×6.11×16.76×7.01× +19%
EV/EBITDA13.99×41.84×28.68×88.19×41.84× -67%
Market Cap₹7,153 Cr₹6,760 Cr₹6,667 Cr₹9,022 Cr₹6,760 Cr +6%
Growth
Revenue CAGR 3Y-33.37%-33.37%
Revenue CAGR 5Y-18.46%-18.46%
Net Income CAGR 3Y-25.17%-25.17%
Revenue YoY (latest Q)-25.80%30.60%33.94%7.37%30.60% -184%
Net Income YoY (latest Q)-33.70%43.77%42.27%45.29%43.77% -177%
Profitability
EBITDA Margin24.38%26.61%14.90%27.38%26.61% -8%
Net Income Margin20.53%19.21%8.65%26.44%19.21% +7%
Return on Common Equity48.02%12.60%12.92%17.86%12.92% +272%
Return on Capital Employed50.87%11.62%14.73%16.26%14.73% +245%
Return on Assets25.64%7.58%7.67%12.10%7.67% +234%
Credit & Quality
Total Debt/Equity0.00×0.34×0.32×0.00×0.32× -100%
Interest Coverage302.73×5.48×11.70×668.43×11.70× +2487%
Scale — latest FY
Revenue / Total Income₹2,013 Cr₹633 Cr₹1,630 Cr₹364 Cr₹633 Cr +218%
Net Income₹413 Cr₹122 Cr₹141 Cr₹96.2 Cr₹122 Cr +240%
Total Assets₹1,612 Cr₹1,604 Cr₹1,837 Cr₹1,721 Cr -6%
EPS₹179.46₹26.39₹24.63₹57.92₹26.39 +580%
Book Value per Share₹374.17₹209.45₹190.61₹324.24₹209.45 +79%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.